The Link between ANRIL Gene RS4977574 Polymorphism and Common Atherosclerosis Cardiovascular Complications: A

Polina V Kniazkova1, Viktoriia Yu Harbuzova1, Vladyslav V Pokhmura1

  • 1Department of Physiology and Pathophysiology with Medical Biology Course, Medical Institute of the Sumy State University, Sumy 40034, Ukraine.

Insights

The ANRIL rs4977574-GG genotype is linked to increased atherosclerosis and cardiovascular risks. This genetic marker may predict complications, particularly in the Ukrainian population.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Atherosclerosis and cardiovascular complications pose significant health challenges.
  • Genetic factors play a crucial role in the development of these conditions.
  • The ANRIL gene is implicated in cardiovascular disease risk.

Purpose of the Study:

  • To investigate the association between the ANRIL rs4977574 polymorphism and the risk of atherosclerosis and cardiovascular complications.
  • To explore the relationship between this polymorphism and lipid profiles.
  • To determine the potential of rs4977574 as a genetic marker in a Ukrainian population.

Main Methods:

  • Case-control study involving patients with acute coronary syndrome (ACS), patients with large artery stenosis (LAS), and healthy controls.
  • Real-time PCR for ANRIL rs4977574 genotyping.
  • Statistical analysis using SPSS software.

Main Results:

  • A significant association was found between the rs4977574 polymorphism and the risk of atherosclerosis and cardiovascular complications under a recessive model (OR = 1.551, p = 0.025).
  • The polymorphism was also linked to altered serum levels of total cholesterol (p = 0.021) and LDL (p = 0.022).
  • Specifically, the rs4977574 polymorphism was associated with an increased risk of ACS (OR = 1.501, p = 0.048) but not LAS (p > 0.05).

Conclusions:

  • The ANRIL rs4977574-GG genotype may serve as a genetic marker for atherosclerosis and cardiovascular complications.
  • This finding holds potential significance for risk stratification and personalized medicine in the Ukrainian population.
  • Further research is warranted to elucidate the precise mechanisms underlying this association.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
40
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
29
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
20
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.6K